Prot#LTI-302: A Global, Open-Label, Extension Study for Participants in LIQ861 Trials to Evaluate the Long-term Safety of Inhaled LIQ861(Treprostinil) in Pulmonary Arterial Hypertension (WHO Group 1) Patients

Project: Research project

Project Details

StatusFinished
Effective start/end date4/29/19 → 4/29/22

Funding

  • Nuventra, Inc. (Prot#LTI-302 // Prot#LTI-302)
  • Liquidia Technologies, Inc. (Prot#LTI-302 // Prot#LTI-302)